{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:28:17Z","timestamp":1791559697473,"version":"4.3.4"},"reference-count":165,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008333","name":"University of Alabama at Birmingham","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008333","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011305","name":"The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center","doi-asserted-by":"publisher","award":["5P30CAO13148-47"],"award-info":[{"award-number":["5P30CAO13148-47"]}],"id":[{"id":"10.13039\/100011305","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.phrs.2026.108136","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T16:50:57Z","timestamp":1770828657000},"page":"108136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Cytokine epigenetics network for gastric cancer progression and chemoresistance"],"prefix":"10.1016","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4989-5234","authenticated-orcid":false,"given":"Ganji Purnachandra","family":"Nagaraju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0061-9327","authenticated-orcid":false,"given":"Seema","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mundla","family":"Srilatha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8934-6312","authenticated-orcid":false,"given":"Irina","family":"Nakashidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassel F.","family":"El-Rayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2026.108136_bib1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","article-title":"Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention","volume":"20","author":"Thrift","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phrs.2026.108136_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40364-024-00720-8","article-title":"The burden of Gastric Cancer and possible risk factors from 1990 to 2021, and projections until 2035: findings from the Global Burden of Disease Study 2021","volume":"13","author":"Qin","year":"2025","journal-title":"Biomark. Res."},{"key":"10.1016\/j.phrs.2026.108136_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101404","article-title":"The current and future incidence and mortality of gastric cancer in 185 countries, 2020\u201340: A population-based modelling study","volume":"47","author":"Morgan","year":"2022","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.phrs.2026.108136_bib4","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.3748\/wjg.v29.i16.2452","article-title":"Updates on global epidemiology, risk and prognostic factors of gastric cancer","volume":"29","author":"Yang","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2026.108136_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/201703","article-title":"Epigenetic regulation of inflammatory cytokines and associated genes in human malignancies","volume":"2015","author":"Yasmin","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.phrs.2026.108136_bib6","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1080\/14737159.2022.2159381","article-title":"Epigenetic signatures in gastric cancer: current knowledge and future perspectives","volume":"22","author":"Sogutlu","year":"2022","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.phrs.2026.108136_bib7","article-title":"Epigenetic modulation of cytokine expression in gastric cancer: influence on angiogenesis, metastasis and chemoresistance","volume":"15 - 2024","author":"Reyes","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108136_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cells8101143","article-title":"Epigenetic regulation of inflammatory cytokine-induced epithelial-to-mesenchymal cell transition and cancer stem cell generation","volume":"8","author":"Markopoulos","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2026.108136_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108640","article-title":"Therapeutic targeting of DNA methylation alterations in cancer","volume":"258","author":"Lee","year":"2024","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2026.108136_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010217","article-title":"Role of JAK\/STAT3 Signaling in the regulation of metastasis, the transition of cancer stem cells, and chemoresistance of cancer by Epithelial-Mesenchymal transition","volume":"9","author":"Jin","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2026.108136_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cytogfr.2016.08.002","article-title":"The CXCL8-CXCR1\/2 pathways in cancer","volume":"31","author":"Liu","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.phrs.2026.108136_bib12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41467-023-35948-9","article-title":"G\u00e9rard, IFN\u03b3 signaling in cytotoxic T cells restricts anti-tumor responses by inhibiting the maintenance and diversity of intra-tumoral stem-like T cells","volume":"14","author":"Mazet","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108136_bib13","first-page":"277","article-title":"The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy","volume":"2","author":"Yang","year":"2022","journal-title":"J. Natl. Cancer Cent."},{"key":"10.1016\/j.phrs.2026.108136_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/pros.23716","article-title":"Long non-coding RNA CCAT1\/miR-148a\/PKC\u03b6 prevents cell migration of prostate cancer by altering macrophage polarization","volume":"79","author":"Liu","year":"2019","journal-title":"Prostate"},{"key":"10.1016\/j.phrs.2026.108136_bib15","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.cmet.2021.08.006","article-title":"Exosomes as mediators of intercellular crosstalk in metabolism","volume":"33","author":"Isaac","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2026.108136_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1023177","article-title":"The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers","volume":"12","author":"Huang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2026.108136_bib17","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3390\/cancers17101691","article-title":"Interleukin-6 IS A Crucial Factor in Shaping the Inflammatory Tumor Microenvironment in Ovarian Cancer and Determining Its Hot Or Cold Nature with Diagnostic and Prognostic Utilities","volume":"17","author":"Amer","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2026.108136_bib18","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.phrs.2026.108136_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189207","article-title":"Structure, function, signaling pathways and clinical therapeutics: The translational potential of STAT3 as a target for cancer therapy","volume":"1879","author":"Shi","year":"2024","journal-title":"Biochimica et Biophysica Acta (BBA) Reviews Cancer"},{"key":"10.1016\/j.phrs.2026.108136_bib20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41419-025-07481-8","article-title":"Both direct and indirect suppression of MCL1 synergizes with BCLXL inhibition in preclinical models of gastric cancer","volume":"16","author":"Zhang","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2026.108136_bib21","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s13193-024-01975-1","article-title":"Expression of EMT markers snail, slug, and twist and their association with known prognostic indicators of breast cancer","volume":"15","author":"Jacob","year":"2024","journal-title":"Indian J. Surg. Oncol."},{"key":"10.1016\/j.phrs.2026.108136_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211069012","article-title":"Tumor promoting roles of IL-10, TGF-\u03b2, IL-4, and IL-35: Its implications in cancer immunotherapy","volume":"10","author":"Mirlekar","year":"2022","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.phrs.2026.108136_bib23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13045-025-01684-4","article-title":"Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance","volume":"18","author":"Shang","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.phrs.2026.108136_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25042232","article-title":"Autocrine Regulation of Interleukin-6 via the Activation of STAT3 and Akt in Cardiac Myxoma Cells","volume":"25","author":"Jougasaki","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108136_bib25","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1182\/blood-2003-06-2007","article-title":"SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak\/STAT pathway","volume":"103","author":"Chim","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2026.108136_bib26","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.26110","article-title":"STAT3 is constitutively acetylated on lysine 685 residues in chronic lymphocytic leukemia cells","volume":"9","author":"Rozovski","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2026.108136_bib27","article-title":"STAT3 and epithelial-mesenchymal transitions in carcinomas","volume":"3","author":"Wendt","year":"2014","journal-title":"Jakstat"},{"key":"10.1016\/j.phrs.2026.108136_bib28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3892\/ijo.2024.5636","article-title":"Role of STAT3 in cancer cell epithelial-mesenchymal transition","volume":"64","author":"Zhang","year":"2024","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.phrs.2026.108136_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16061113","article-title":"Paracrine regulation and immune system pathways in the inflammatory tumor microenvironment of lung cancer: insights into oncogenesis and immunotherapeutic strategies","volume":"16","author":"Batrash","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2026.108136_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8120637","article-title":"STAT3 and p53: dual target for cancer therapy","volume":"8","author":"Pham","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2026.108136_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s12276-022-00736-w","article-title":"The mechanism of HMGB1 secretion and release","volume":"54","author":"Chen","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.phrs.2026.108136_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11030694","article-title":"Role of IL-6\/STAT3 axis in resistance to cisplatin in gastric cancers","volume":"11","author":"Laurino","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2026.108136_bib33","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/08923973.2018.1455208","article-title":"MiR-340 affects gastric cancer cell proliferation, cycle, and apoptosis through regulating SOCS3\/JAK-STAT signaling pathway","volume":"40","author":"Xiao","year":"2018","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.phrs.2026.108136_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/hel.70015","article-title":"Innate Immunity in Helicobacter pylori Infection and Gastric Oncogenesis","volume":"30","author":"Zhang","year":"2025","journal-title":"Helicobacter"},{"key":"10.1016\/j.phrs.2026.108136_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16162797","article-title":"Targeting IL-8 and its receptors in prostate cancer: inflammation, stress response, and treatment resistance","volume":"16","author":"McClelland","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2026.108136_bib36","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.3390\/molecules27175686","article-title":"Natural small molecules in gastrointestinal tract and associated cancers: molecular insights and targeted therapies","volume":"27","author":"Islam","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2026.108136_bib37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41416-024-02735-2","article-title":"Tumour cell-derived serglycin promotes IL-8 secretion of CAFs in gastric cancer","volume":"131","author":"Li","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phrs.2026.108136_bib38","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202152878","article-title":"TIFA has dual functions in Helicobacter pylori-induced classical and alternative NF-\u03baB pathways","volume":"22","author":"Maubach","year":"2021","journal-title":"EMBO Rep."},{"key":"10.1016\/j.phrs.2026.108136_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.153062","article-title":"Nicotine stimulates IL-8 expression via ROS\/NF-\u03baB and ROS\/MAPK\/AP-1 axis in human gastric cancer cells","volume":"466","author":"Lian","year":"2022","journal-title":"Toxicology"},{"key":"10.1016\/j.phrs.2026.108136_bib40","doi-asserted-by":"crossref","first-page":"13988","DOI":"10.1073\/pnas.2335921100","article-title":"Atypical methylation of the interleukin-8 gene correlates strongly with the metastatic potential of breast carcinoma cells","volume":"100","author":"De Larco","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2026.108136_bib41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13148-023-01426-8","article-title":"The prognostic value and immune correlation of IL18 expression and promoter methylation in renal cell carcinoma","volume":"15","author":"Wang","year":"2023","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.phrs.2026.108136_bib42","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1034\/j.1398-9995.1999.00099.x","article-title":"Biologic functions of the IFN-gamma receptors","volume":"54","author":"Tau","year":"1999","journal-title":"Allergy"},{"key":"10.1016\/j.phrs.2026.108136_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156208","article-title":"Interferon-gamma (IFN-\u03b3): Reviewing its mechanisms and signaling pathways on the regulation of endothelial barrier function","volume":"166","author":"Ng","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.phrs.2026.108136_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097633","article-title":"A conserved motif in the linker domain of STAT1 transcription factor is required for both recognition and release from high-affinity DNA-binding sites","volume":"9","author":"H\u00fcntelmann","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2026.108136_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113683","article-title":"Role of interferon-gamma (IFN-\u03b3) and IFN-\u03b3 receptor 1\/2 (IFN\u03b3R1\/2) in regulation of immunity, infection, and cancer development: IFN-\u03b3-dependent or independent pathway","volume":"155","author":"Ding","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2026.108136_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1190333","article-title":"Dysregulation in IFN-\u03b3 signaling and response: the barricade to tumor immunotherapy","volume":"14","author":"Han","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2026.108136_bib47","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.it.2014.03.004","article-title":"Heterogeneity in immune responses: from populations to single cells","volume":"35","author":"Satija","year":"2014","journal-title":"Trends Immunol."},{"key":"10.1016\/j.phrs.2026.108136_bib48","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12964-024-02012-y","article-title":"New insights into the structure domain and function of NLR family CARD domain containing 5","volume":"23","author":"Zhu","year":"2025","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.phrs.2026.108136_bib49","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190668","article-title":"A super enhancer controls expression and chromatin architecture within the MHC class II locus","volume":"217","author":"Majumder","year":"2020","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.phrs.2026.108136_bib50","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.tig.2020.12.006","article-title":"Polycomb Gene Silencing Mechanisms: PRC2 Chromatin Targeting, H3K27me3 'Readout', and Phase Separation-Based Compaction","volume":"37","author":"Guo","year":"2021","journal-title":"Trends Genet"},{"key":"10.1016\/j.phrs.2026.108136_bib51","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.7150\/thno.49235","article-title":"Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2026.108136_bib52","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12943-025-02255-4","article-title":"The epigenetic hallmarks of immune cells in cancer","volume":"24","author":"Ji","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2026.108136_bib53","first-page":"230","article-title":"Transcriptional synergism between NF-\u03baB and STAT1","volume":"47","author":"Hiroi","year":"2005","journal-title":"J. Oral. Biosci."},{"key":"10.1016\/j.phrs.2026.108136_bib54","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s12967-023-04079-6","article-title":"Pharmacologic inhibition of IL11\/STAT3 signaling increases MHC-I expression and T cell infiltration","volume":"21","author":"Xiong","year":"2023","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.phrs.2026.108136_bib55","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.phrs.2026.108136_bib56","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1186\/s12885-025-14211-y","article-title":"Explosive tumor growth in a patient with colon cancer is associated with reduced neoantigen levels and decreased interferon-gamma (IFN-\u03b3) signaling","volume":"25","author":"Wang","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.phrs.2026.108136_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.791272","article-title":"Transforming Growth Factor-Beta (TGF-\u03b2) Signaling in Cancer-A Betrayal Within","volume":"13","author":"Baba","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.phrs.2026.108136_bib58","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12935-024-03353-x","article-title":"Smad2\/3\/4 complex could undergo liquid liquid phase separation and induce apoptosis through TAT in hepatocellular carcinoma","volume":"24","author":"Li","year":"2024","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.phrs.2026.108136_bib59","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1752-0509-5-85","article-title":"A deterministic map of Waddington's epigenetic landscape for cell fate specification","volume":"5","author":"Bhattacharya","year":"2011","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.phrs.2026.108136_bib60","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/OTT.S451108","article-title":"The Role and Mechanism of the Histone Methyltransferase G9a in Tumors: Update","volume":"17","author":"Zhou","year":"2024","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.phrs.2026.108136_bib61","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3390\/cancers3010982","article-title":"Epigenetic Alteration by DNA Promoter Hypermethylation of Genes Related to Transforming Growth Factor-\u03b2 (TGF-\u03b2) Signaling in Cancer","volume":"3","author":"Khin","year":"2011","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.phrs.2026.108136_bib62","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.semcdb.2014.01.009","article-title":"TGF-\u03b2 signaling to chromatin: how Smads regulate transcription during self-renewal and differentiation","volume":"32","author":"Gaarenstroom","year":"2014","journal-title":"Semin Cell Dev. Biol."},{"key":"10.1016\/j.phrs.2026.108136_bib63","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1038\/s41598-024-83977-1","article-title":"KAT2B inhibits proliferation and invasion via inactivating TGF-\u03b2\/Smad3 pathway-medicated autophagy and EMT in epithelial ovarian cancer","volume":"15","author":"Yao","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2026.108136_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111878","article-title":"The loss of epithelial Smad4 drives immune evasion via CXCL1 while displaying vulnerability to combinatorial immunotherapy in gastric cancer","volume":"41","author":"An","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2026.108136_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/biology10090854","article-title":"Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment","volume":"10","author":"Azwar","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.phrs.2026.108136_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166512","article-title":"Epigenetic regulation of autophagy in gastrointestinal cancers","volume":"1868","author":"Ghavami","year":"2022","journal-title":"Biochim. Et. Biophys. Acta (BBA) Mol. Basis Dis."},{"key":"10.1016\/j.phrs.2026.108136_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1486783","article-title":"MiRNAs function in the development of resistance against doxorubicin in cancer cells: targeting ABC transporters","volume":"15","author":"Lu","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108136_bib68","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12967-015-0438-8","article-title":"Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer","volume":"13","author":"Mao","year":"2015","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.phrs.2026.108136_bib69","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3892\/etm.2022.11154","article-title":"MicroRNA-21-5p acts via the PTEN\/Akt\/FOXO3a signaling pathway to prevent cardiomyocyte injury caused by high glucose\/high fat conditions","volume":"23","author":"Han","year":"2022","journal-title":"Exp. Ther. Med"},{"key":"10.1016\/j.phrs.2026.108136_bib70","article-title":"miR-96-5p enhances cell proliferation and invasion via targeted regulation of ZDHHC5 in gastric cancer","volume":"40","author":"Wang","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.phrs.2026.108136_bib71","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cellsig.2017.04.009","article-title":"Cytidine monophosphate kinase is inhibited by the TGF-\u03b2 signalling pathway through the upregulation of miR-130b-3p in human epithelial ovarian cancer","volume":"35","author":"Zhou","year":"2017","journal-title":"Cell Signal"},{"key":"10.1016\/j.phrs.2026.108136_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.133594","article-title":"Exosomal miR-130b-3p suppresses metastasis of non-small cell lung cancer cells by targeting DEPDC1 via TGF-\u03b2 signaling pathway","volume":"275","author":"Lv","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phrs.2026.108136_bib73","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12964-022-00840-4","article-title":"MicroRNAs as the critical regulators of tyrosine kinase inhibitors resistance in lung tumor cells","volume":"20","author":"Maharati","year":"2022","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.phrs.2026.108136_bib74","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.canlet.2021.05.037","article-title":"miR-105-5p regulates PD-L1 expression and tumor immunogenicity in gastric cancer","volume":"518","author":"Miliotis","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2026.108136_bib75","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.trsl.2020.12.003","article-title":"Tumor-derived extracellular vesicles containing microRNA-1290 promote immune escape of cancer cells through the Grhl2\/ZEB1\/PD-L1 axis in gastric cancer","volume":"231","author":"Liang","year":"2021","journal-title":"Transl. Res"},{"key":"10.1016\/j.phrs.2026.108136_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2024.102294","article-title":"CIRCULATING miR-1-3p, miR-96-5p, miR-148a-3p, and miR-375-3p Support Differentiation Between Prostate Cancer and Benign Prostate Lesions","volume":"23","author":"Osiecki","year":"2025","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.phrs.2026.108136_bib77","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ncrna.2021.12.001","article-title":"microRNAs in cancer chemoresistance: The sword and the shield","volume":"6","author":"Mondal","year":"2021","journal-title":"Noncoding RNA Res"},{"key":"10.1016\/j.phrs.2026.108136_bib78","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100235R","article-title":"miR-148a-3p silences the CANX\/MHC-I pathway and impairs CD8(+) T cell-mediated immune attack in colorectal cancer","volume":"35","author":"Zheng","year":"2021","journal-title":"Faseb J."},{"key":"10.1016\/j.phrs.2026.108136_bib79","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12943-024-02201-w","article-title":"The miR-23a\/27a\/24\u2009\u2212\u20092 cluster drives immune evasion and resistance to PD-1\/PD-L1 blockade in non-small cell lung cancer","volume":"23","author":"Luo","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2026.108136_bib80","doi-asserted-by":"crossref","DOI":"10.1038\/s41417-025-00950-4","article-title":"Long non-coding RNAs and signaling networks in non-small cell lung cancer: mechanistic insights into tumor pathogenesis","author":"Elimam","year":"2025","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.phrs.2026.108136_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/biom14060608","article-title":"Long Non-Coding RNAs in Drug Resistance of Gastric Cancer: Complex Mechanisms and Potential Clinical Applications","volume":"14","author":"Meng","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.phrs.2026.108136_bib82","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.7150\/jca.58185","article-title":"Long Noncoding RNA LIT3527 Knockdown induces Apoptosis and Autophagy through inhibiting mTOR pathway in Gastric Cancer Cells","volume":"12","author":"Wang","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.phrs.2026.108136_bib83","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/jcb.29370","article-title":"PCAT-1 contributes to cisplatin resistance in gastric cancer through epigenetically silencing PTEN via recruiting EZH2","volume":"121","author":"Li","year":"2020","journal-title":"J. Cell Biochem"},{"key":"10.1016\/j.phrs.2026.108136_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12092001","article-title":"Epigenetic Regulation of DNA Methylation and RNA Interference in Gastric Cancer: A 2024 Update","volume":"12","author":"Lupan","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2026.108136_bib85","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2147\/IJN.S354314","article-title":"Exosomal lncRNA HOTAIR Promotes the Progression and Angiogenesis of Endometriosis via the miR-761\/HDAC1 Axis and Activation of STAT3-Mediated Inflammation","volume":"17","author":"Zhang","year":"2022","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.phrs.2026.108136_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076294","article-title":"Long Non-Coding RNAs (lncRNAs) as Regulators of the PI3K\/AKT\/mTOR Pathway in Gastric Carcinoma","volume":"24","author":"Riquelme","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108136_bib87","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12943-025-02363-1","article-title":"Wnt\/\u03b2-catenin mediated signaling pathways in cancer: recent advances, and applications in cancer therapy","volume":"24","author":"Wu","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2026.108136_bib88","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.2147\/OTT.S251625","article-title":"LncRNA SNHG15 Contributes to Immuno-Escape of Gastric Cancer Through Targeting miR141\/PD-L1","volume":"13","author":"Dang","year":"2020","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.phrs.2026.108136_bib89","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41556-021-00672-3","article-title":"LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy","volume":"23","author":"Li","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phrs.2026.108136_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1519103","article-title":"Deciphering the mysteries of MEG3 LncRNA and its implications in genitourinary cancers","volume":"15","author":"Assal","year":"2025","journal-title":"Front Oncol."},{"key":"10.1016\/j.phrs.2026.108136_bib91","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ncrna.2023.12.005","article-title":"Circular RNA-mediated miRNA sponge & RNA binding protein in biological modulation of breast cancer","volume":"9","author":"Zhu","year":"2024","journal-title":"Noncoding RNA Res."},{"key":"10.1016\/j.phrs.2026.108136_bib92","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s10147-022-02122-y","article-title":"CircRNA PVT1 promotes proliferation and chemoresistance of osteosarcoma cells via the miR-24-3p\/KLF8 axis","volume":"27","author":"Wang","year":"2022","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.phrs.2026.108136_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104612","article-title":"Circular RNAs as key regulators in cancer hallmarks: New progress and therapeutic opportunities","volume":"207","author":"Hussen","year":"2025","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"key":"10.1016\/j.phrs.2026.108136_bib94","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41392-021-00788-w","article-title":"Crosstalk between circRNAs and the PI3K\/AKT signaling pathway in cancer progression","volume":"6","author":"Xue","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.phrs.2026.108136_bib95","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.omto.2021.04.007","article-title":"Circular RNAs act as regulators of autophagy in cancer","volume":"21","author":"Zhou","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.phrs.2026.108136_bib96","first-page":"1611","article-title":"Circular RNAs in gastrointestinal cancer: Current knowledge, biomarkers and targeted therapy (Review)","volume":"46","author":"Zhao","year":"2020","journal-title":"Int J. Mol. Med"},{"key":"10.1016\/j.phrs.2026.108136_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2020.101562","article-title":"Circular RNA MTO1 suppresses tumorigenesis of gastric carcinoma by sponging miR-3200-5p and targeting PEBP1","volume":"52","author":"Hu","year":"2020","journal-title":"Mol. Cell Probes"},{"key":"10.1016\/j.phrs.2026.108136_bib98","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2147\/ITT.S485670","article-title":"JAK-STAT Signaling in Autoimmunity and Cancer","volume":"14","author":"Parveen","year":"2025","journal-title":"Immunotargets Ther."},{"key":"10.1016\/j.phrs.2026.108136_bib99","article-title":"Understanding the complexity of tumor-associated macrophages: Druggable and therapeutic insights","author":"Li","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phrs.2026.108136_bib100","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1158\/2326-6066.CIR-16-0295","article-title":"Tumor-associated macrophages promote epigenetic silencing of gelsolin through DNA Methyltransferase 1 in Gastric Cancer cells","volume":"5","author":"Wang","year":"2017","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.phrs.2026.108136_bib101","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.3390\/cancers16193410","article-title":"Tumor-associated macrophages as major immunosuppressive cells in the tumor microenvironment","volume":"16","author":"Ghebremedhin","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2026.108136_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173090","article-title":"Macrophage M1\/M2 polarization","volume":"877","author":"Yunna","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108136_bib103","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3748\/wjg.v19.i8.1182","article-title":"A. Smith Mde, DNA and histone methylation in gastric carcinogenesis","volume":"19","author":"Calcagno","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2026.108136_bib104","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/labinvest.2012.61","article-title":"Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers","volume":"92","author":"Yun","year":"2012","journal-title":"Lab. Investig."},{"key":"10.1016\/j.phrs.2026.108136_bib105","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fimmu.2022.976196","article-title":"Epigenetic therapy reprograms M2-type tumor-associated macrophages into an M1-like phenotype by upregulating miR-7083-5p","volume":"13","author":"Vadevoo","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108136_bib106","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13105","article-title":"The Interplay Between Helicobacter pylori and Suppressors of Cytokine Signaling (SOCS) Molecules in the Development of Gastric Cancer and Induction of Immune Response","volume":"29","author":"Jafarzadeh","year":"2024","journal-title":"Helicobacter"},{"key":"10.1016\/j.phrs.2026.108136_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/v15030651","article-title":"IL-8 Secreted by Gastric Epithelial Cells Infected with Helicobacter pylori CagA Positive Strains Is a Chemoattractant for Epstein-Barr Virus Infected B Lymphocytes","volume":"15","author":"Dom\u00ednguez-Mart\u00ednez","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.phrs.2026.108136_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1393799","article-title":"SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation","volume":"15","author":"Morelli","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108136_bib109","unstructured":"J. Fahrer, B. Kaina, O6-METHYLGUANINE-DNA METHYLTRANSFERASE (MGMT) IN THE DEFENSE AGAINST N, Clin Oncol 29 e262-e265."},{"key":"10.1016\/j.phrs.2026.108136_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1347530","article-title":"Epigenetic modulation of cytokine expression in gastric cancer: influence on angiogenesis, metastasis and chemoresistance","volume":"15","author":"Reyes","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108136_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105801","article-title":"Histone Modifications and Non-Coding RNAs: Mutual Epigenetic Regulation and Role in Pathogenesis","volume":"23","author":"Bure","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108136_bib112","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.3390\/ijms25063381","article-title":"Gastric Cancer in the Era of Epigenetics","volume":"25","author":"Christodoulidis","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108136_bib113","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.3390\/cancers17172798","article-title":"The Targeted Inhibition of Histone Lysine Demethylases as a Novel Promising Anti-Cancer Therapeutic Strategy\u2014An Update on Recent Evidence","volume":"17","author":"Paluszczak","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2026.108136_bib114","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5306\/wjco.v6.i5.111","article-title":"P. Pimentel-Nunes, Helicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditions","volume":"6","author":"Lib\u00e2nio","year":"2015","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.phrs.2026.108136_bib115","doi-asserted-by":"crossref","first-page":"21770","DOI":"10.1002\/jcp.28925","article-title":"Epigenetic changes in gastric cancer induction by Helicobacter pylori","volume":"234","author":"Yousefi","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.phrs.2026.108136_bib116","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00223-025-01367-9","article-title":"Regulation of Skeletogenic Pathways by m6A RNA Modification: A Comprehensive Review","volume":"116","author":"Ahi","year":"2025","journal-title":"Calcif. Tissue Int"},{"key":"10.1016\/j.phrs.2026.108136_bib117","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41420-023-01485-z","article-title":"Role of N6-methyladenosine RNA modification in gastric cancer","volume":"9","author":"Ding","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.phrs.2026.108136_bib118","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.1038\/sj.onc.1209505","article-title":"Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis","volume":"25","author":"Wendt","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2026.108136_bib119","doi-asserted-by":"crossref","first-page":"6738","DOI":"10.1038\/s41598-025-91100-1","article-title":"The MiR-139-5p and CXCR4 axis may play a role in high glucose-induced inflammation by regulating monocyte migration","volume":"15","author":"Li","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2026.108136_bib120","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.7150\/jca.47083","article-title":"MiR-135-5p inhibits TGF-\u03b2-induced epithelial-mesenchymal transition and metastasis by targeting SMAD3 in breast cancer","volume":"11","author":"Yang","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.phrs.2026.108136_bib121","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40364-025-00779-x","article-title":"Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies","volume":"13","author":"Liu","year":"2025","journal-title":"Biomark. Res."},{"key":"10.1016\/j.phrs.2026.108136_bib122","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.1007\/s11033-023-08671-3","article-title":"CXCL5 promotes tumorigenesis and angiogenesis of glioblastoma via JAK-STAT\/NF-\u03bab signaling pathways","volume":"50","author":"Mao","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.phrs.2026.108136_bib123","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.semcancer.2022.03.019","article-title":"Epigenetic regulation of CXCR4 signaling in cancer pathogenesis and progression","volume":"86","author":"Alsayed","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.phrs.2026.108136_bib124","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.3390\/cancers17132172","article-title":"MicroRNAs in Cancer Immunology: Master Regulators of the Tumor Microenvironment and Immune Evasion, with Therapeutic Potential","volume":"17","author":"Zare","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2026.108136_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111925","article-title":"PRMT5-FOXM1 axis activates \u03b2-catenin\/IL8 signaling to drive angiogenesis of gastric cancer","volume":"134","author":"Liu","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.phrs.2026.108136_bib126","doi-asserted-by":"crossref","first-page":"269","DOI":"10.7150\/ijms.102976","article-title":"PUF60 Promotes Chemoresistance Through Drug Efflux and Reducing Apoptosis in Gastric Cancer","volume":"22","author":"Liu","year":"2025","journal-title":"Int J. Med Sci."},{"key":"10.1016\/j.phrs.2026.108136_bib127","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14040940","article-title":"The Bright and the Dark Side of TGF-\u03b2 Signaling in Hepatocellular Carcinoma: Mechanisms, Dysregulation, and Therapeutic Implications","volume":"14","author":"Gungor","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.phrs.2026.108136_bib128","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2147\/JHC.S300165","article-title":"Blocking the CCL5-CCR5 Axis Using Maraviroc Promotes M1 Polarization of Macrophages Cocultured with Irradiated Hepatoma Cells","volume":"8","author":"Zhuang","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.phrs.2026.108136_bib129","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1096\/fj.201701456RR","article-title":"Helicobacter pylori-induced miR-135b-5p promotes cisplatin resistance in gastric cancer","volume":"33","author":"Shao","year":"2019","journal-title":"Faseb J."},{"key":"10.1016\/j.phrs.2026.108136_bib130","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/s12935-021-02300-4","article-title":"Mesenchymal stem cells in cancer progression and anticancer therapeutic resistance","volume":"21","author":"Xuan","year":"2021","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.phrs.2026.108136_bib131","article-title":"Activation of long-non-coding RNA NEAT1 sponging microRNA-147 inhibits radiation damage by targeting PDPK1 in troxerutin radioprotection","volume":"26","author":"Hu","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.phrs.2026.108136_bib132","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41698-025-01003-7","article-title":"Epigenetic regulators in cancer therapy and progression","volume":"9","author":"Marei","year":"2025","journal-title":"NPJ Precis Oncol."},{"key":"10.1016\/j.phrs.2026.108136_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194969","article-title":"An Epigenetic Perspective on Intra-Tumour Heterogeneity: Novel Insights and New Challenges from Multiple Fields","volume":"13","author":"Beyes","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2026.108136_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101821","article-title":"Epigenetic modifications: Key players in cancer heterogeneity and drug resistance","volume":"39","author":"Sadida","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.phrs.2026.108136_bib135","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41577-023-00856-y","article-title":"Targeting IL-6 trans-signalling: past, present and future prospects","volume":"23","author":"Rose-John","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2026.108136_bib136","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s40265-014-0249-x","article-title":"Siltuximab: first global approval","volume":"74","author":"Markham","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.phrs.2026.108136_bib137","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1097\/01.HS9.0000847428.60021.87","article-title":"P1140: TIME TO TUMOR, SYMPTOMATIC AND LABORATORY RESPONSES FOLLOWING SILTUXIMAB TREATMENT IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE","volume":"6","author":"van Rhee","year":"2022","journal-title":"HemaSphere"},{"key":"10.1016\/j.phrs.2026.108136_bib138","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/ndt\/gfu233","article-title":"Interleukin-6 in renal disease and therapy","volume":"30","author":"Jones","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.phrs.2026.108136_bib139","article-title":"1216 Phenotypic signatures of circulating neoantigen-reactive CD8+ T cells in patients with metastatic cancers","author":"Krishna","year":"2023","journal-title":"BMJ Spec. J."},{"key":"10.1016\/j.phrs.2026.108136_bib140","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.7150\/ijbs.4614","article-title":"Interleukin-6-a key regulator of colorectal cancer development","volume":"8","author":"Waldner","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phrs.2026.108136_bib141","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5483\/BMBRep.2023-0024","article-title":"Immunogenic cell death in cancer immunotherapy","volume":"56","author":"Choi","year":"2023","journal-title":"BMB Rep."},{"key":"10.1016\/j.phrs.2026.108136_bib142","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1182\/blood-2018-99-118238","article-title":"Tocilizumab to Prevent Infusion-Related Events in Patients with Chronic Lymphocytic Leukemia and Co-Morbidities Treated with Obinutuzumab and Chlorambucil: Results from the Randomized Phase Ib GALACTA Trial","volume":"132","author":"Freeman","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2026.108136_bib143","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.767939","article-title":"Exploiting the STAT3 nexus in cancer-associated fibroblasts to improve cancer therapy","volume":"12","author":"Allam","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108136_bib144","doi-asserted-by":"crossref","DOI":"10.1200\/JCO-25-01631","article-title":"Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cachexia","author":"Chen","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phrs.2026.108136_bib145","doi-asserted-by":"crossref","first-page":"A65","DOI":"10.1136\/annrheumdis-2013-eular.251","article-title":"OP0046 Tofacitinib, an Oral Janus Kinase Inhibitor, in a Rheumatoid Arthritis Open-Label Extension Study Following Adalimumab Therapy in a Phase 3 Randomised Clinical Trial","volume":"72","author":"Genovese","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2026.108136_bib146","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1093\/ibd\/izy160","article-title":"Outcomes of pregnancies with maternal\/paternal exposure in the tofacitinib safety databases for ulcerative colitis","volume":"24","author":"Mahadevan","year":"2018","journal-title":"Inflamm. bowel Dis."},{"key":"10.1016\/j.phrs.2026.108136_bib147","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s10120-024-01514-5","article-title":"Janus kinase inhibitor overcomes resistance to immune checkpoint inhibitor treatment in peritoneal dissemination of gastric cancer in C57BL\/6 J mice","volume":"27","author":"Du","year":"2024","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.phrs.2026.108136_bib148","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10555-020-09948-w","article-title":"Pancreatic adenocarcinoma: molecular drivers and the role of targeted therapy","volume":"40","author":"Al-Share","year":"2021","journal-title":"Cancer Metastas.. Rev."},{"key":"10.1016\/j.phrs.2026.108136_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155316","article-title":"Pterostilbene suppresses gastric cancer proliferation and metastasis by inhibiting oncogenic JAK2\/STAT3 signaling: In vitro and in vivo therapeutic intervention","volume":"128","author":"He","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2026.108136_bib150","article-title":"Pacritinib (PAC) vs best available therapy (BAT) in myelofibrosis (MF): Outcomes in patients (pts) with baseline (BL) thrombocytopenia","author":"Harrison","year":"2016","journal-title":"Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.phrs.2026.108136_bib151","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.1016\/S2152-2650(24)01440-X","article-title":"MPN-497 Impact of Pacritinib on Symptoms in Thrombocytopenic Myelofibrosis Patients Who Require Red Blood Cell Transfusion","volume":"24","author":"Oh","year":"2024","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.phrs.2026.108136_bib152","article-title":"Inhibitors Targeting Multiple Janus Kinases From Zanthoxylum simulans Mediate Inhibition and Apoptosis Against Gastric Cancer Cells via the Estrogen Pathway","volume":"10 - 2022","author":"Tian","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.phrs.2026.108136_bib153","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2013.63","article-title":"A novel STAT inhibitor, OPB-31121, has a significant antitumor effect on leukemia with STAT-addictive oncokinases","volume":"3","author":"Hayakawa","year":"2013","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.phrs.2026.108136_bib154","article-title":"First-in-man phase I clinical trial evaluating TTI-101, an orally bioavailable, small molecule inhibitor of STAT3, in patients with advanced solid tumors","author":"Tsimberidou","year":"2021","journal-title":"Wolters Kluwer Health"},{"key":"10.1016\/j.phrs.2026.108136_bib155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.18632\/oncotarget.1468","article-title":"A novel immunomodulatory and molecularly targeted strategy for refractory Hodgkin's lymphoma","volume":"5","author":"Subbiah","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2026.108136_bib156","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.947568","article-title":"The multifaceted role of STAT3 in NK-cell tumor surveillance","volume":"13","author":"Witalisz-Siepracka","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108136_bib157","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/cvr\/cvv103","article-title":"Emerging translational approaches to target STAT3 signalling and its impact on vascular disease","volume":"106","author":"Dutzmann","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2026.108136_bib158","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.23_suppl.222","article-title":"Predictive and pharmacodynamic biomarkers for combination therapy in stage III-IV melanoma: A Simon phase II trial (NCT03999749)","author":"Mizutani","year":"2024","journal-title":"Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.phrs.2026.108136_bib159","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1158\/2326-6066.CIR-20-0272","article-title":"Antitumor T-cell immunity contributes to pancreatic cancer immune resistance","volume":"9","author":"Ajina","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.phrs.2026.108136_bib160","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/s12916-022-02605-9","article-title":"Bifunctional anti-PD-L1\/TGF-\u03b2RII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trial","volume":"20","author":"Liu","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.phrs.2026.108136_bib161","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s12672-024-01225-4","article-title":"CTGF, FN1, IL-6, THBS1, and WISP1 genes and PI3K-Akt signaling pathway as prognostic and therapeutic targets in gastric cancer identified by gene network modeling","volume":"15","author":"Khoshdel","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.phrs.2026.108136_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114616","article-title":"Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within interleukin-6 family cytokines","volume":"43","author":"Huber","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2026.108136_bib163","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.biopha.2016.04.070","article-title":"Interference of lysine-specific demethylase 1 inhibits cellular invasion and proliferation in vivo in gastric cancer MKN-28 cells","volume":"82","author":"Li","year":"2016","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2026.108136_bib164","article-title":"Effect of SHR-1701 on chemotherapy (chemo)-induced myelosuppression: data from a phase 3 study in HER2-negative gastric\/gastroesophageal junction adenocarcinoma (G\/GEJA), American Society","author":"Peng","year":"2025","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.phrs.2026.108136_bib165","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2024.1509924","article-title":"Advances in CRISPR-Cas technology and its applications: revolutionising precision medicine","volume":"6","author":"Azeez","year":"2024","journal-title":"Front. Genome Ed."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826000514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826000514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:44:54Z","timestamp":1778795094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826000514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":165,"alternative-id":["S1043661826000514"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108136","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokine epigenetics network for gastric cancer progression and chemoresistance","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108136","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108136"}}